FDA Drug Application (018163) for RESTORIL by MALLINCKRODT INC

Back to FDA Applications sponsored by MALLINCKRODT INC

Application Number018163
Product Number001
FormCAPSULE;ORAL
Dosage15MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRESTORIL
Active IngredientTEMAZEPAM

Active IngredientCount
List of drugs with Active Ingredient TEMAZEPAM3


Back to FDA Applications sponsored by MALLINCKRODT INC